​​​​​​Aging-US: Neurodegeneration in subjective cognitive decline

09-21-2021

Aging-US published "The interplay between gray matter and white matter neurodegeneration in subjective cognitive decline" which reported that subjective cognitive complaints were assessed through 9 questions covering amnestic and non-amnestic cognitive domains. In these author’s cohort, 123 individuals endorsed from one to six subjective cognitive complaints, while 102 individuals reported zero complaints.

A higher number of complaints was associated with reduced hippocampal volume, cortical thinning in several frontal and temporal areas and the insula, and higher MD across the WM skeleton, with a tendency to spare the occipital lobe. SCD-related cortical thinning and increased MD were associated with each other and jointly contributed to complaints, but the contribution of cortical thinning to the number of complaints was stronger.

Dr. Nira Cedres from The Karolinska Institutet as well as The Stockholm University said, "Multiple pathologies can co-exist in cognitively unimpaired individuals, causing neurodegeneration years before the onset of cognitive decline."

Dr. Nira Cedres from The Karolinska Institutet as well as The Stockholm University said, "Multiple pathologies can co-exist in cognitively unimpaired individuals, causing neurodegeneration years before the onset of cognitive decline."

Increasing research is trying to ascertain whether individuals are able to subjectively detect such neurodegeneration, motivating the emergence of concepts like subjective cognitive decline, as a risk factor for dementia. Several studies showed that SCD may be a harbinger of Alzheimer’s disease. However, community-based studies show that SCD can also be associated with cerebrovascular disease, age-related tauopathy, and emotional factors such as depressive symptomatology.

While some authors reported reduced GM volume or thickness in hippocampus, precuneus, cingulum and frontal cortex in SCD individuals compared with healthy controls, other authors reported no differences, or even increased GM volume in fusiform gyrus and occipital areas in SCD. In addition, previous studies operationalized SCD mostly based on episodic memory complaints and had a strong focus on AD. Hong et al. investigated 46 SCD patients, of which 19 had a high risk of progressing to AD and 27 had a low risk of progressing to AD based on age, APOE genotype, and cognitive performance. Using DTI, Hong et al. showed that SCD patients at a high risk of progressing to AD had greater neurodegeneration in frontotemporal WM areas, while no differences were found in cortical thickness.

The overall goal of the current study was to extend the previous research on GM and WM neurodegeneration in SCD.

Figure 2. Mediation analysis. (A) Represents mediation model 1: subjective cognitive complaints as the dependent variable (Y), the average MD as the independent variable (X), and the average cortical thickness as the mediator (M); (B) Represents mediation model 2: subjective cognitive complaints as the dependent variable (Y), the average MD as the independent variable (X), and the TIV-corrected hippocampal volume (left+right) as the mediator (M). (C) Represents mediation model 3: subjective cognitive complaints as the dependent variable (Y), cortical thickness as the independent variable (X), and the average MD as the mediator (M); (D) Represents mediation model 4: subjective cognitive complaints as the dependent variable (Y), the TIV-corrected hippocampal volume (left+right) as the independent variable (X), and the average MD as the mediator (M). Note: age was not a significant covariate in models 1 and 3. SCC: subjective cognitive complaints; ACME: average causal mediation effect; ADE: average direct effect; M: mediator; Magnitude of the mediation effect: ACME / total effect; X: independent variable; Y: dependent variable. *p<0.05; **p<0.01; ***p<0.001.

The Cedres Research Team concluded in their Aging-US Research Output that this study is one of the few in investigating the association between GM and WM neurodegeneration in SCD. These data suggest an association between neurodegeneration processes affecting the GM and WM in SCD individuals. However, GM neurodegeneration seemed to have a stronger contribution to SCD in our community-based cohort, highlighting brain areas that are typically not targeted by AD. This finding suggests the contribution of non-AD pathologies to SCD, and encourages that future studies extend imaging analysis to brain areas other than those typically involved in AD.

Full Text - https://www.aging-us.com/article/203467/text

Correspondence to: Nira Cedres email: nira.cedres@ki.se

Keywords: subjective cognitive decline, gray matter, white matter, aging, mediation

About Aging-US:

Cancer and aging are two sides of age-related tumorigenesis.

The mission of the journal is to understand the mechanisms surrounding aging and age-related diseases, including cancer as the main cause of death in the modern aged population.

The journal aims to promote 1) treatment of age-related diseases by slowing down aging, 2) validation of anti-aging drugs by treating age-related diseases, and 3) prevention of cancer by inhibiting aging. (Cancer and COVID-19 are age-related diseases.)

Please visit our website at www.Aging-US.com and connect with us:

For media inquiries, please contact media@impactjournals.com.